vTv Therapeutics Inc [VTVT] stock prices are up 53.13% to $22.74 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VTVT shares have gain 51.60% over the last week, with a monthly amount glided 7.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel downgraded its rating to Hold on April 10, 2018, and dropped its price target to $1. On March 08, 2018, ROTH Capital initiated with a Buy rating and assigned a price target of $17 on the stock. Northland Capital started tracking the stock assigning a Outperform rating and suggested a price target of $28 on February 08, 2018. H.C. Wainwright initiated its recommendation with a Buy and recommended $13 as its price target on September 26, 2016. Canaccord Genuity started tracking with a Buy rating for this stock on September 04, 2015, and assigned it a price target of $15. In a note dated August 24, 2015, Stifel initiated an Buy rating and provided a target price of $17 on this stock.
The stock price of vTv Therapeutics Inc [VTVT] has been fluctuating between $12.12 and $30.99 over the past year. vTv Therapeutics Inc [NASDAQ: VTVT] shares were valued at $22.74 at the most recent close of the market.
Analyzing the VTVT fundamentals
Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -24.21%, Pretax Profit Margin comes in at -21.75%, and Net Profit Margin reading is -18.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -2.65 and Total Capital is -0.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.83 points at the first support level, and at 12.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.32, and for the 2nd resistance point, it is at 31.90.
Ratios To Look Out For
It’s worth pointing out that vTv Therapeutics Inc [NASDAQ:VTVT]’s Current Ratio is 6.69. In addition, the Quick Ratio stands at 6.69 and the Cash Ratio stands at 6.47. Considering the valuation of this stock, the price to sales ratio is 72.54, the price to book ratio is 3.96.
Transactions by insiders
Recent insider trading involved SEKHRI PAUL J, Pres, CEO and Exec Chairperson, that happened on Nov 15 ’24 when 3156.0 shares were purchased. Pres, CEO and Exec Chairperson, SEKHRI PAUL J completed a deal on Nov 18 ’24 to buy 1844.0 shares.
